Publications of Marschall S Runge - ReachNC

188 Publications

This view shows all the publications associated to this researcher. Select a tab to view the documents within each secion. If you are an authorized user, you can add content by selecting the Edit your profile button above. Access to this tool is managed by a project team at your institution.

Jump to:

Books
Book Chapters
Conference Proceedings
Meeting Abstracts
Presentations
Technical Reports
Other Written Works

188 Publications from Scopus

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2012

Rui-Hai Zhou; Aleksandr E. Vendrov; Igor Tchivilev; Xi-Lin Niu; Kimberly C. Molnar; Mauricio Rojas; Jacqueline D. Carter; Haiyan Tong; George A. Stouffer; Nageswara R. Madamanchi; et al.

Mitochondrial oxidative stress in aortic stiffening with age the role of smooth muscle cell function
Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32(3):745-755.

1
2.
2010

Nageswara R. Madamanchi; Marschall S. Runge

NADPH oxidases and atherosclerosis: Unraveling the details
American Journal of Physiology - Heart and Circulatory Physiology. 2010;298(1):H1-H2.

2
3.
2010

Xi-Lin Niu; Nageswara R. Madamanchi; Aleksandr E. Vendrov; Igor Tchivilev; Mauricio Rojas; Chaitanya Madamanchi; Ralph P. Brandes; Karl-Heinz Krause; Julia Humphries; Alberto Smith; et al.

Nox activator 1: A potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries
Circulation. 2010;121(4):549-559.

25
4.
2010

Aleksandr E. Vendrov; Nageswara R. Madamanchi; Xi-Lin Niu; Kimberly C. Molnar; Mason Runge; Cédric Szyndralewiez; Patrick Page; Marschall S. Runge

NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis
Journal of Biological Chemistry. 2010;285(34):26545-26557.

17
5.
2010

Elizabeth Monaghan-Benson; John Hartmann; Aleksandr E. Vendrov; Steve Budd; Grace Byfield; Augustus Parker; Faisal Ahmad; Wei Huang; Marschall Runge; Keith Burridge; et al.

The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization
American Journal of Pathology. 2010;177(4):2091-2102.

9
6.
2010

Nageswara R. Madamanchi; Rui-Hai Zhou; Aleksandr E. Vendrov; Xi-Lin Niu; Marschall S. Runge

Does oxidative DNA damage cause atherosclerosis and metabolic syndrome?: New insights into which came first: The chicken or the egg
Circulation Research. 2010;107(8):940-942.

3
7.
2010

Marschall S Runge; Kimberly Molnar; Nageswara R Madamanchi

"Old" hearts and arteries: the role of oxidative stress.
Transactions of the American Clinical and Climatological Association. 2010;121:52-58; discussion 59-5860.

2
8.
2008

Urmila P Kodavanti; Mette C Schladweiler; Peter S Gilmour; J Grace Wallenborn; Bhaskar S Mandavilli; Allen D Ledbetter; David C Christiani; Marschall S Runge; Edward D Karoly; Daniel L Costa; et al.

The role of particulate matter-associated zinc in cardiac injury in rats.
Environmental health perspectives. 2008;116(1):13-20.

24
9.
2008

Igor Tchivilev; Nageswara R. Madamanchi; Aleksandr E. Vendrov; Xi-Lin Niu; Marschall S. Runge

Identification of a protective role for protein phosphatase 1cγ1 against oxidative stress-induced vascular smooth muscle cell apoptosis
Journal of Biological Chemistry. 2008;283(32):22193-22205.

10
10.
2007

Nageswara R. Madamanchi; Marschall S. Runge

Mitochondrial dysfunction in atherosclerosis
Circulation Research. 2007;100(4):460-473.

165
11.
2007

Xi-Lin Niu; Juxiang Li; Zeenat S. Hakim; Mauricio Rojas; Marschall S. Runge; Nageswara R. Madamanchi

Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury
Journal of Biological Chemistry. 2007;282(27):19808-19819.

15
12.
2007

Aleksandr E. Vendrov; Zeenat S. Hakim; Nageswara R. Madamanchi; Mauricio Rojas; Chaitanya Madamanchi; Marschall S. Runge

Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27(12):2714-2721.

54
13.
2006

Aleksandr E. Vendrov; Nageswara R. Madamanchi; Zeenat S. Hakim; Mauricio Rojas; Marschall S. Runge

Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis
Circulation Research. 2006;98(10):1254-1263.

41
14.
2006

Masuo Ohashi; Marschall S. Runge; Frank M. Faraci; Donald D. Heistad

MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26(10):2331-2336.

41
15.
2006

Nageswara R. Madamanchi; Marschall S. Runge

Five easy pieces: The obesity paradigm
Circulation Research. 2006;98(5):576-578.

2
16.
2006

Nageswara R. Madamanchi; Igor Tchivilev; Marschall S. Runge

Genetic markers of oxidative stress and coronary atherosclerosis
Current Atherosclerosis Reports. 2006;8(3):177-183.

5
17.
2006

Sherry Kurtz; Karen P. McKinnon; Marschall S. Runge; Jenny P.-Y. Ting; Miriam Braunstein

The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response
Infection and Immunity. 2006;74(12):6855-6864.

41
18.
2005

N.R. Madamanchi; Z.S. Hakim; M.S. Runge

Oxidative stress in atherogenesis and arterial thrombosis: The disconnect between cellular studies and clinical outcomes
Journal of Thrombosis and Haemostasis. 2005;3(2):254-267.

80
19.
2005

Marschall S Runge; Natrajan Subramanian; George A Stouffer

Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start?
Transactions of the American Clinical and Climatological Association. 2005;116:273-280; discussion 281.

1
20.
2005

Nageswara R. Madamanchi; Aleksandr Vendrov; Marschall S. Runge

Oxidative stress and vascular disease
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(1):29-38.

498
21.
2005

Zaidoun Salah; Myriam Maoz; Irit Cohen; Galina Pizov; Dov Pode; Marschall S. Runge; Rachel Bar-Shavit

Identification of a novel functional androgen response element within hPar1 promoter: Implications to prostate cancer progression
FASEB Journal. 2005;19(1):62-72.

18
22.
2005

Christal G. Young; Cynthia A. Knight; Kasey C. Vickers; David Westbrook; Nageswara R. Madamanchi; Marschall S. Runge; Harry Ischiropoulos; Scott W. Ballinger

Differential effects of exercise on aortic mitochondria
American Journal of Physiology - Heart and Circulatory Physiology. 2005;288(4 57-4):H1683-H1689.

13
23.
2005

Nageswara R. Madamanchi; Sung-Kwon Moon; Zeenat S. Hakim; Shantres Clark; Ali Mehrizi; Cam Patterson; Marschall S. Runge

Differential activation of mitogenic signaling pathways in aortic smooth muscle cells deficient in superoxide dismutase isoforms
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(5):950-956.

37
24.
2004

R.V. Kelly; M.G. Cohen; M.S. Runge; G.A. Stouffer

The no-reflow phenomenon in coronary arteries
Journal of Thrombosis and Haemostasis. 2004;2(11):1903-1907.

17
25.
2004

C.E. Hagemeyer; I. Tomic; U. Weirich; J. Graeber; T. Nordt; M.S. Runge; C. Bode; Karlheinz Peter

Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase
Journal of Thrombosis and Haemostasis. 2004;2(5):797-803.

15
26.
2004

Sung-Kwon Moon; Byung-Yoon Cha; Young-Choon Lee; Kyung-Soo Nam; Marschall S. Runge; Cam Patterson; Cheorl-Ho Kim

Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells
Experimental Gerontology. 2004;39(1):123-131.

11
27.
2004

Cam Patterson; Marschall S. Runge; Nageswara Madamanchi

Younger than Yesterday: Is Vascular Senescence a Two-Way Street?
Circulation Research. 2004;94(6):703-705.

0
28.
2004

Christoph E. Hagemeyer; Ivo Tomic; Patrick Jaminet; Uta Weirich; Nicole Bassler; Meike Schwarz; Marschall S. Runge; Christoph Bode; Karlheinz Peter

Fibrin-targeted direct factor Xa inhibition: Construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide
Thrombosis and Haemostasis. 2004;92(1):47-53.

15
29.
2004

Nageswara Madamanchi; Xilin Liu; Marschall S. Runge

A new slice of pie? Estrogen regulation of plasminogen activator inhibitor-1
Circulation Research. 2004;95(3):228-229.

1
30.
2004

Thomas M. Runge; Marschall S. Runge

Limiting brain and lung damage after coronary artery bypass grafting: An alternative to conventional coronary artery bypass graft
Clinical Cardiology. 2004;27(11):594-598.

3
31.
2003

Nageswara R. Madamanchi; Zhao Y. Hu; Fengzhi Li; Chris Horaist; Sung-Kwon Moon; Cam Patterson; Marshall S. Runge

Erratum: A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis (Biochimica et Biophysica Acta (2002) 1576 (237-245))
Biochimica et Biophysica Acta - Gene Structure and Expression. 2003;1626(1-3):106.

0
32.
2003

Karlheinz Peter; Amitabh Gupta; Thomas Nordt; Simone Bauer; Marschall S. Runge; Christoph Bode

Construction and in vitro testing of a novel Fab-hirudin-based fusion protein that targets fibrin and inhibits thrombin in a factor Xa-dependent manner
Journal of Cardiovascular Pharmacology. 2003;42(2):237-244.

6
33.
2002

Marschall S. Runge

Extracellular mediators in atherosclerosis and thrombosis
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22(8):1256.

0
34.
2002

Allan R. Brasier; Adrian Recinos III; Mohsen S. Eledrisi; Marschall S. Runge

Vascular inflammation and the renin-angiotensin system
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22(8):1257-1266.

330
35.
2002

Nageswara R. Madamanchi; Cam Patterson; Marschall S. Runge

HIV therapies and atherosclerosis: Answers or questions?
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22(11):1758-1760.

2
36.
2002

Nageswara R Madamanchi; Zhao Y Hu; Fengzhi Li; Chris Horaist; Sung-Kwon Moon; Cam Patterson; Marschall S Runge

A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesis
Biochimica et Biophysica Acta - Gene Structure and Expression. 2002;1576(3):237-245.

11
37.
2002

Scott W. Ballinger; Cam Patterson; Cynthia A. Knight-Lozano; David L. Burow; Caryl A. Conklin; Zhaoyong Hu; Johannes Reuf; Chris Horaist; Russell Lebovitz; et al.

Mitochondrial integrity and function in atherogenesis
Circulation. 2002;106(5):544-549.

155
38.
2001

K.T. Nguyen; S.G. Eskin; C. Patterson; M.S. Runge; L.V. McIntire

Shear stress reduces protease activated receptor-1 expression in human endothelial cells
Annals of Biomedical Engineering. 2001;29(2):145-152.

26
39.
2001

Larry J. Thompson; Jihong Jiang; Nageswara Madamanchi; Marschall S. Runge; Cam Patterson

PTP-ε, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation
American Journal of Physiology - Heart and Circulatory Physiology. 2001;281(1 50-1):H396-H403.

20
40.
2001

Sung-Kwon Moon; Larry J. Thompson; Nageswara Madamanchi; Scott Ballinger; John Papaconstantinou; Chris Horaist; Marschall S. Runge; Cam Patterson

Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells
American Journal of Physiology - Heart and Circulatory Physiology. 2001;280(6 49-6):H2779-H2788.

71
41.
2001

George A. Stouffer; Cam Patterson; N. Madamanchi; Marschall S. Runge

Role of reactive oxygen species in angiotensin II signaling: The plot thickens
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21(4):471-472.

2
42.
2001

Johannes Ruef; Martin Moser; Christoph Bode; Wolfgang Kübler; Marschall S. Runge

4-Hydroxynonenal induces apoptosis, NF-κB-activation and formation of 8-isoprostane in vascular smooth muscle cells
Basic Research in Cardiology. 2001;96(2):143-150.

51
43.
2001

Nageswara R. Madamanchi; Suzhen Li; Cam Patterson; Marschall S. Runge

Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21(3):321-326.

113
44.
2001

Marschall S. Runge; George A. Stouffer; Richard G. Sheahan; Stamatios Lerakis; W. Robert Taylor; Mary Lynch; Craig M. Litman; Stephen D. Clements; Trevor D. Thompson; Randolph P. Martin

The role of transesophageal echocardiography in the diagnosis and management of patients with aortic perivalvular abscesses
American Journal of the Medical Sciences. 2001;321(2):152-155.

22
45.
2001

Patricia A. Barry-Lane; Cam Patterson; Marié Van Der Merwe; Zhaoyong Hu; Stephen M. Holland; Edward T.H. Yeh; Marschall S. Runge

p47phox is required for atherosclerotic lesion progression in ApoE^-/- mice
Journal of Clinical Investigation. 2001;108(10):1513-1522.

250
46.
2001

Masood Ahmad; Tianrong Xie; Marti McCulloch; Gerard Abreo; Marschall Runge

Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects
Journal of the American College of Cardiology. 2001;37(5):1395-1402.

91
47.
2001

Nageswara R. Madamanchi; Suzhen Li; Cam Patterson; Marschall S. Runge

Thrombin Regulates Vascular Smooth Muscle Cell Growth and Heat Shock Proteins via the JAK-STAT Pathway
Journal of Biological Chemistry. 2001;276(22):18915-18924.

83
48.
2001

Kytai T. Nguyen; Stacie R. Frye; Suzanne G. Eskin; Cam Patterson; Marschall S. Runge; Larry V. McIntire

Cyclic strain increases protease-activated receptor-1 expression in vascular smooth muscle cells
Hypertension. 2001;38(5):1038-1043.

27
49.
2001

Christopher R DeFilippi; Salvatore Rosanio; Monica Tocchi; Rohit J Parmar; Marjorie A Potter; Barry F Uretsky; Marschall S Runge

Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: In-hospital and long-term outcomes
Journal of the American College of Cardiology. 2001;37(8):2042-2049.

54
50.
2001

Cam Patterson; George A. Stouffer; Nageswara Madamanchi; Marschall S. Runge

New tricks for old dogs: Nonthrombotic effects of thrombin in vessel wall biology
Circulation Research. 2001;88(10):987-997.

101
51.
2001

Alan L. Hinderliter; Marschall S. Runge

Who's on first? Does hypertension in type I diabetics result from nephropathy or metabolic alterations?
Circulation. 2001;104(5):508-510.

11
52.
2000

Hiroshi Saito; Cam Patterson; Zhaoyong Hu; Marschall S. Runge; Ulka Tipnis; Mala Sinha; John Papaconstantinou

Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia
American Journal of Physiology - Heart and Circulatory Physiology. 2000;279(5 48-5):H2241-H2248.

31
53.
2000

M.S. Runge; G.A. Stouffer; R.G. Sheahan; S. Yamamoto; V.G. Tsyplenkova; T.N. James

Morphological patterns of death by myocytes in arrhythmogenic right ventricular dysplasia
American Journal of the Medical Sciences. 2000;320(5):310-319.

21
54.
2000

A.R. Brasier; M. Jamaluddin; Y. Han; C. Patterson; M.S. Runge

Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor
Molecular and Cellular Biochemistry. 2000;212(1-2):155-169.

110
55.
2000

S. Lick; M.S. Runge; G.A. Stouffer; R.G. Sheahan

Surgical therapy for cardiomyopathy
American Journal of the Medical Sciences. 2000;320(2):135-143.

1
56.
2000

Johannes Ruef; Si-Qi Liu; Christoph Bode; Monica Tocchi; Sanjay Srivastava; Marschall S. Runge; Aruni Bhatnagar

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20(7):1745-1752.

74
57.
2000

Christopher R. Defilippi; Monica Tocchi; Rohit J. Parmar; Salvatore Rosanio; Gerard Abreo; Marjorie A. Potter; Marschall S. Runge; Barry F. Uretsky

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: Angiographic correlates and long-term clinical outcomes
Journal of the American College of Cardiology. 2000;35(7):1827-1834.

68
58.
2000

Gerard Abreo; Daniel J. Lenihan; Peter Nguyen; Marschall S. Runge

High-output heart failure resulting from a remote traumatic aorto-caval fistula: Diagnosis by echocardiography
Clinical Cardiology. 2000;23(4):304-306.

11
59.
2000

Cam Patterson; Nageswara R. Madamanchi; Marschall S. Runge

The oxidative paradox: Another piece in the puzzle
Circulation Research. 2000;87(12):1074-1076.

31
60.
2000

Scott W. Ballinger; Cam Patterson; Chang-Ning Yan; Richard Doan; David L. Burow; Christal G. Young; F. Michael Yakes; Bennett Van Houten; Carol A. Ballinger; Bruce A. Freeman; et al.

Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells
Circulation Research. 2000;86(9):960-966.

203
61.
2000

Karlheinz Peter; Justin Graeber; Sergey Kipriyanov; Monika Zewe-Welschof; Marschall S. Runge; Wolfgang Kübler; Melvyn Little; Christoph Bode

Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa
Circulation. 2000;101(10):1158-1164.

27
62.
2000

Cam Patterson; Marschall S. Runge

Therapeutic myocardial angiogenesis via vascular endothelial growth factor gene therapy: Moving on down the road
Circulation. 2000;102(9):940-942.

15
63.
1999

M.S. Runge

The role of oxidative stress in atherosclerosis: the hope and the hype.
Transactions of the American Clinical and Climatological Association. 1999;110:119-129; discussion 129-130.

4
64.
1999

C. Patterson; S. Ballinger; G.A. Stouffer; M.S. Runge

Antioxidant vitamins: Sorting out the good and the not so good
Journal of the American College of Cardiology. 1999;34(4):1216-1218.

10
65.
1999

Johannes Ruef; Thomas K. Nordt; Karlheinz Peter; Marschall S. Runge; Wolfgang Kübler; Christoph Bode

A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation
Thrombosis and Haemostasis. 1999;82(1):109-114.

6
66.
1999

Maria Papadaki; Suzanne G. Eskin; Johannes Ruef; Marschall S. Runge; Larry V. McIntire

Fluid shear stress as a regulator of gene expression in vascular cells: Possible correlations with diabetic abnormalities
Diabetes Research and Clinical Practice. 1999;45(2-3):89-99.

9
67.
1999

C.R. DeFilippi; M.S. Runge

Evaluating the chest pain patient. Scope of the problem
Cardiology Clinics. 1999;17(2):307-326.

3
68.
1999

B.F. Uretsky; M.S. Runge

Unstable angina: Preface
Cardiology Clinics. 1999;17(2):xiii-xvii.

0
69.
1999

K. Nguyen; C. Patterson; M. Runge; S. Eskin; L. McIntire

Arterial shear stress downregulates thrombin receptor expression and attenuates thrombin-induced response in endothelial cells
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings. 1999;1:9.

0
70.
1999

S. Rosanio; M. Tocchi; C. Patterson; M.S. Runge

Prevention of restenosis after percutneous coronary interventions: The medical approach
Thrombosis and Haemostasis. 1999;82(SUPPL. 1):164-170.

24
71.
1999

J. Ruef; K. Peter; T.K. Nordt; M.S. Runge; W. Kubler; C. Bode

Oxidative stress and atherosclerosis: Its relationship to growth factors, thrombus formation and therapeutic approaches
Thrombosis and Haemostasis. 1999;82(SUPPL. 1):32-37.

60
72.
1999

David L. Ware; Marschall S. Runge

The 'graphic experience' as clinical science: Thoughts on the precordial leads of wolferth and wood
American Journal of the Medical Sciences. 1999;318(5):336-338.

0
73.
1999

Youqi Han; Marschall S. Runge; Allan R. Brasier

Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κb transcription factors
Circulation Research. 1999;84(6):695-703.

226
74.
1999

Martin Moser; Thomas Nordt; Karlheinz Peter; Johannes Ruef; Benedikt Kohler; Marc Schmittner; Richard Smalling; Wolfgang Kübler; Christoph Bode; Marschall S. Runge

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase
Circulation. 1999;100(18):1858-1864.

29
75.
1999

Cam Patterson; Johannes Ruef; Nageswara R. Madamanchi; Patricia Barry-Lane; Zhaoyong Hu; Chris Horaist; Carol A. Ballinger; Alan R. Brasier; Christoph Bode; Marschall S. Runge

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo
Journal of Biological Chemistry. 1999;274(28):19814-19822.

246
76.
1999

Salvatore Rosanio; Monica Tocchi; David Cutler; Barry F. Uretsky; George A. Stouffer; Christopher R. DeFilippi; Edward J. MacInerney; Susan R. Runge; Joann Aaron; Javier Otero; et al.

Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: Analysis of a waiting list registry
Journal of the American Medical Association. 1999;282(2):145-152.

22
77.
1999

C. Patterson; M.S. Runge

Therapeutic angiogenesis the new electrophysiology
Circulation. 1999;99(20):2614-2616.

19
78.
1998

D.C. Gulba; C. Bode; M.S. Runge; K. Huber

Thrombolytic agents - An updated overview
Fibrinolysis and Proteolysis. 1998;12(SUPPL. 2):39-58.

13
79.
1998

George A. Stouffer; Marschall S. Runge

The role of secondary growth factor production in thrombin-induced proliferation of vascular smooth muscle cells
Seminars in Thrombosis and Hemostasis. 1998;24(2):145-150.

38
80.
1998

M.S. Runge; G.A. Stouffer; R.G. Sheahan; L. Mott; R.G. Sheahan; C.R. DeFilippi

Sudden cardiac death in a teenager: A review of Kawasaki disease
American Journal of the Medical Sciences. 1998;315(4):273-278.

2
81.
1998

Ashok Gowda; Chun-Jie Yang; Gregory K. Asimakis; Johannes Ruef; Sohi Rastegar; Marschall S. Runge; Massoud Motamedi

Cardioprotection by local heating: Improved myocardial salvage after ischemia and reperfusion
Annals of Thoracic Surgery. 1998;65(5):1241-1247.

32
82.
1998

George A. Stouffer; Zhaoyong Hu; Mansoor Sajid; Husong Li; Guifang Jin; Marian T. Nakada; Stephen R. Hanson; Marschall S. Runge

β₁ Integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
Circulation. 1998;97(9):907-915.

113
83.
1998

Yaxu Wu; Johannes Ruef; Gadiparthi N. Rao; Cam Patterson; Marschall S. Runge

Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells
Biochemical Journal. 1998;330(3):1469-1474.

21
84.
1998

Maria Papadaki; Johannes Ruef; Kytai Truong Nguyen; Fengzhi Li; Cam Patterson; Suzanne G. Eskin; Larry V. McIntire; Marschall S. Runge

Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells
Circulation Research. 1998;83(10):1027-1034.

43
85.
1998

Nageswara R. Madamanchi; Richard D. Bukoski; Marschall S. Runge; Gadiparthi N. Rao

Arachidonic acid activates jun N-terminal kinase in vascular smooth muscle cells
Oncogene. 1998;16(3):417-422.

32
86.
1998

J. Ruef; G.N. Rao; F. Li; C. Bode; C. Patterson; A. Bhatnagar; M.S. Runge

Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal
Circulation. 1998;97(11):1071-1078.

104
87.
1998

Chang-Ning Van; Fengzhi Li; Cam Patterson; Marschall S. Runge

High-voltage and high-salt buffer facilitates electroporation of human aortic smooth-muscle cells
BioTechniques. 1998;24(4):590-592.

2
88.
1997

C. Bode; T.K. Nordt; K. Peter; J. Ruef; M.S. Runge; W. Kübier

Targeting of thrombolytic and antithrombotic agents
Fibrinolysis and Proteolysis. 1997;11(SUPPL. 2):63-70.

3
89.
1997

J. Ruef; C. Bode; M.S. Runge

Effects of fluid shear stress on atherogenesis and hemostasis
Fibrinolysis and Proteolysis. 1997;11(SUPPL. 2):159-164.

0
90.
1997

C. Bode; K. Peter; T. Nordt; B. Kohler; M. Moser; J. Ruef; M.S. Runge

New developments in thrombolytic therapy
Fibrinolysis and Proteolysis. 1997;11(SUPPL. 1):109-114.

5
91.
1997

Stamatios Lerakis; George A. Stouffer; Marschall S. Runge

New thrombolytics. What is under development?
BioDrugs. 1997;8(1):24-32.

5
92.
1997

Johannes Ruef; Zhao Y. Hu; Li-Yan Yin; Yaxu Wu; Stephen R. Hanson; Andrew B. Kelly; Laurence A. Harker; Gadiparthi N. Rao; Marschall S. Runge; et al.

Induction of vascular endothelial growth factor in balloon-injured baboon arteries: A novel role for reactive oxygen species in atherosclerosis
Circulation Research. 1997;81(1):24-33.

117
93.
1997

Cam Patterson; Yaxu Wu; Mu-En Lee; James D. DeVault; Marschall S. Runge; Edgar Haber

Nuclear protein interactions with the human KDR/flk-1 promoter in vivo: Regulation of Sp1 binding is associated with cell type-specific expression
Journal of Biological Chemistry. 1997;272(13):8410-8416.

44
94.
1997

Quinn Capers IV; Jørn Bech Laursen; Toshiki Fukui; Sanjay Rajagopalan; Ichiro Mori; Pingping Lou; Brace A. Freeman; William R. Berrington; Kathy K. Griendling; David G. Harrison; et al.

Vascular thrombin receptor regulation in hypertensive rats
Circulation Research. 1997;80(6):838-844.

29
95.
1997

John F. Schmedtje Jr.; Yan-Shan Ji; W.-L. Liu; Raymond N. DuBois; Marschall S. Runge

Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells
Journal of Biological Chemistry. 1997;272(1):601-608.

530
96.
1997

Christoph Bode; Stephen R. Hanson; John F. Schmedtje Jr.; Edgar Haber; Petra Mehwald; Andrew B. Kelly; Laurence A. Harker; Marschall S. Runge

Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting
Circulation. 1997;95(4):800-804.

17
97.
1997

Hui-Sheng Wang; Fengzhi Li; Marschall S. Runge; Elliot L. Chaikof

Endothelial cells exhibit differential chemokinetic and mitogenic responsiveness to α-thrombin
Journal of Surgical Research. 1997;68(2):139-144.

20
98.
1997

J. Ruef; F. Li; Z. Hu; C. Patterson; M.S. Runge

Thrombin induces generation of reactive oxygen species and expression of p47^PHOX in human aortic smooth muscle cells
FASEB Journal. 1997;11(3):A270.

0
99.
1997

F. Li; P.H. Fritz; C. Yan; J. Ruef; M.S. Runge

Identification of a potential regulatory sequence from a RNA-Coding gene
FASEB Journal. 1997;11(9):A1074.

0
100.
1997

Y. Wu; C. Patterson; C. Horaist; M.S. Runge

Transcriptional regulation of the HTR gene by Sp1 family proteins
FASEB Journal. 1997;11(3):A335.

0
101.
1997

J. Wang; F. Li; S. Wang; S. Lui; C. Patterson; M.S. Runge

Identification and characterization of a novel tetratricopeptide repeat-containing genes
FASEB Journal. 1997;11(9):A1381.

0
102.
1996

Marschall S. Runge; Laurence A. Harker; Christoph Bode; Johannes Ruef; Andrew B. Kelly; Ulla M. Marzec; Elaine Allen; Rafael Caban; Shyh-Yu Shaw; Edgar Haber; et al.

Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons
Circulation. 1996;94(6):1412-1422.

29
103.
1996

Gadiparthi N. Rao; Marschall S. Runge

Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression
Journal of Biological Chemistry. 1996;271(34):20805-20810.

56
104.
1996

G.A. Stouffer; J.F. Schmedtje; D. Gulba; K. Huber; C. Bode; J. Aaron; M.S. Runge

Restenosis following percutaneous revascularization - The potential role of thrombin and the thrombin receptor
Annals of Hematology, Supplement. 1996;73(1):S39-S41.

7
105.
1996

C. Bode; D. Gulba; K. Huber; M.S. Runge

New approaches in plasminogen activator therapy
Annals of Hematology, Supplement. 1996;73(1):S1-S7.

3
106.
1996

K. Huber; M.S. Runge; C. Bode; D. Gulba

Thrombolytic therapy in acute myocardial infarction - Update 1996
Annals of Hematology, Supplement. 1996;73(1):S29-S38.

8
107.
1996

D.C. Gulba; C. Bode; M.S. Runge; K. Huber

Thrombolytic agents - An overview
Annals of Hematology, Supplement. 1996;73(1):S9-S27.

34
108.
1996

C. Bode; M.S. Runge; R.W. Smalling

The future of thrombolysis in the treatment of acute myocardial infarction
European Heart Journal. 1996;17(SUPPL. E):55-60.

28
109.
1996

John F. Schmedtje Jr.; W.L. Liu; Yanshan Ji; Tonya M. Thompson; Marschall S. Runge

Evidence of hypoxia-inducible factor-1 in vascular endothelial and smooth muscle cells
Biochemical and Biophysical Research Communications. 1996;220(3):687-691.

11
110.
1996

Gadiparthi N. Rao; Wayne C. Glasgow; Thomas E. Eling; Marschall S. Runge

Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (Ap-1) activity
Journal of Biological Chemistry. 1996;271(44):27760-27764.

60
111.
1996

Fengzhi Li; Demir Baykal; Chris Horaist; Chang-Ning Yan; Boyd N. Carr; Gadiparthi N. Rao; Marschall S. Runge

Cloning and identification of regulatory sequences of the human thrombin receptor gene
Journal of Biological Chemistry. 1996;271(42):26320-26328.

41
112.
1996

G.A. Stouffer; M.S. Runge

Thrombin and restenosis: Has the question been answered?
Journal of the American College of Cardiology. 1996;28(7):1856-1857.

0
113.
1996

C. Bode; T.K. Nordt; K. Peter; R.W. Smalling; M.S. Runge; W. Kübler

Patency trials with reteplase (r-PA): what do they tell us?
The American journal of cardiology. 1996;78(12 A):16-19.

11
114.
1995

D.A. Cutler; M.S. Runge

86 Years of Buerger's disease - What have we learned?
American Journal of the Medical Sciences. 1995;309(2):74-75.

11
115.
1995

G.N. Rao; P. Delafontaine; M.S. Runge

Thrombin stimulates phosphorylation of insulin-like growth factor-1 receptor, insulin receptor substrate-1, and phospholipase C-γ1 in rat aortic smooth muscle cells
Journal of Biological Chemistry. 1995;270(46):27871-27875.

118
116.
1995

G.N. Rao; M.S. Runge; R.W. Alexander

Hydrogen peroxide activation of cytosolic phospholipase A₂ in vascular smooth muscle cells
BBA - Molecular Cell Research. 1995;1265(1):67-72.

95
117.
1995

L.A. Harker; S.R. Hanson; M.S. Runge

Thrombin hypothesis of thrombus generation and vascular lesion formation
American Journal of Cardiology. 1995;75(6):12B-17B.

102
118.
1995

D. Baykal; J.F. Schmedtje Jr.; M.S. Runge

Role of the thrombin receptor in restenosis and atherosclerosis
American Journal of Cardiology. 1995;75(6):82B-87B.

39
119.
1995

E.L. Chaikof; R. Caban; C.-N. Yan; G.N. Rao; M.S. Runge

Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences
Journal of Biological Chemistry. 1995;270(13):7431-7436.

31
120.
1995

M.S. Runge; J.F. Schmedtje Jr.; C. Horaist; F. Li; J.N. Wilcox; C. Bode

New approaches to inhibiting thrombin's effect on the blood vessel wall
Fibrinolysis. 1995;9(SUPPL. 1):69-73.

1
121.
1995

C. Bode; B. Kohler; R.W. Smalling; M.S. Runge

Reteplase (r-PA): A novel recombinant plasminogen activator
Fibrinolysis. 1995;9(SUPPL. 1):97-99.

5
122.
1995

G.N. Rao; R.W. Alexander; M.S. Runge

Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-fos, c-jun, and c-myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells
Journal of Clinical Investigation. 1995;96(2):842-847.

104
123.
1995

David Cutler; Christoph Bode; Marschall S. Runge

The Promise of New Genetically Engineered Plasminogen Activators
Journal of Vascular and Interventional Radiology. 1995;6(6 PART 2):3S-7S.

2
124.
1994

Christoph Bode; Michael Hudelmayer; Petra Mehwald; Simone Bauer; Mathias Freitag; Eberhard Von Hodenberg; John B. Newell; Wolfgang Kübler; Edgar Haber; Marschall S. Runge

Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin
Circulation. 1994;90(4 I):1956-1963.

28
125.
1994

T.W. Love; T. Quertermous; M.S. Runge; K.D. Michelson; G.R. Matsueda; E. Haber

Attachment of an antifibrin antibody to the amino terminus of tissue-type plasminogen activator impairs stimulation by fibrin
Fibrinolysis. 1994;8(5):326-332.

3
126.
1994

H. Kai; K.K. Griendling; B. Lassegue; J.D. Ollerenshaw; M.S. Runge; R.W. Alexander

Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor
Hypertension. 1994;24(4):523-527.

55
127.
1994

C. Bode; T.K. Nordt; M.S. Runge

Thrombolytic therapy in acute myocardial infarction - Selected recent developments
Annals of Hematology. 1994;69(4):S35-S40.

19
128.
1994

D.J. Hayzer; G. Cicila; C. Cockerham; K.K. Griendling; P. Delafontaine; Shi Chung Ng; M.S. Runge

Endothelin A and B receptors are down-regulated in the hearts of hypertensive rats
American Journal of the Medical Sciences. 1994;307(3):222-227.

8
129.
1994

Ira M. Lubin; John F. Healey; Dorothea Scandella; Marschall S. Runge; Pete Lollar

Elimination of a major inhibitor epitope in factor VIII
Journal of Biological Chemistry. 1994;269(12):8639-8641.

33
130.
1994

G.N. Rao; A.S. Baas; W.C. Glasgow; T.E. Eling; M.S. Runge; R.W. Alexander

Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells
Journal of Biological Chemistry. 1994;269(51):32586-32591.

197
131.
1994

David J. Hayzer; Mamoru Shoji; Theresa M. Kim; Marschall S. Runge; Stephen R. Hanson

Alternative splicing of the mRNA encoding baboon glycoprotein receptor GPIIb
Gene. 1994;151(1-2):267-271.

1
132.
1994

P. Delafontaine; L. Ku; J.J. Ververis; C. Cohen; M.S. Runge; R.W. Alexander

Epitope mapping of the α-chain of the insulin-like growth factor I receptor using antipeptide antibodies
Journal of Molecular and Cellular Cardiology. 1994;26(12):1659-1673.

2
133.
1994

Josiah N. Wilcox; Jose Rodriguez; Romesh Subramanian; Jeremy Ollerenshaw; Chizheng Zhong; David J. Hayzer; Christopher Horaist; Stephen R. Hanson; Alan Lumsden; Tarek A. Salam; et al.

Characterization of thrombin receptor expression during vascular lesion formation
Circulation Research. 1994;75(6):1029-1038.

113
134.
1994

Laurence A. Harker; Josiah N. Wilcox; Marcshall S. Runge; Andrew B. Kelly; Alan B. Lumsden; Stephen R. Hanson

Thrombosis/antithrombotic therapy. The role of thrombin in vascular lesion formation in nonhuman primates
Journal of Vascular Surgery. 1994;20(1):122-123.

0
135.
1993

William G. Paxton; Marschall Runge; Christopher Horaist; Cynthia Cohen; R. Wayne Alexander; Kenneth E. Bernstein

Immunohistochemical localization of rat angiotensin II AT₁ receptor
American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 1993;264(6 33-6):F989-F995.

122
136.
1993

D.J. Hayzer; M. Shoji; T.M. Kim; M.S. Runge; S.R. Hanson

Characterization of a cDNA encoding the β-chain of baboon receptor glycoprotein GPIb
Gene. 1993;127(2):271-272.

2
137.
1993

M.S. Runge; C. Bode

Inhibition of platelets and thrombin: Implications for treatment of coronary artery thrombosis
Zeitschrift fur Kardiologie. 1993;82(SUPPL. 2):83-88.

3
138.
1993

C. Bode; M.S. Runge

Future developments in thrombolytic therapy
Zeitschrift fur Kardiologie. 1993;82(SUPPL. 2):187-190.

0
139.
1993

I.M. Lubin; R. Caban; M.S. Runge

The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator
Journal of Biological Chemistry. 1993;268(8):5550-5556.

2
140.
1993

Mamoru Shoji; David J. Hayzer; Theresa M. Kim; Marschall S. Runge; Stephen R. Hanson

Human and baboon integrin β₅ subunit-encoding mRNAs have alternative polyadenylation sites
Gene. 1993;133(2):307-308.

3
141.
1993

Ted W. Love; Thomas Quertermous; Paul J. Zavodny; Marschall S. Runge; Chuan-Chu Chou; Debora Mullins; Paul L. Huang; Janet M. Schnee; Anita S. Kestin; Christopher E. Savard; et al.

High-level expression of antibody-plasminogen activator fusion proteins in hybridoma cells
Thrombosis Research. 1993;69(2):221-229.

3
142.
1992

I.M. Lubin; D.J. Hayzer; M.S. Runge

Strategies for the design of novel thrombolytic and antithrombolytic agents
Trends in Cardiovascular Medicine. 1992;2(3):84-89.

3
143.
1992

C. Zhong; D.J. Hayzer; M.S. Runge

Molecular cloning of a cDNA encoding a novel protein related to the neuronal vesicle protein synaptophysin
Biochimica et Biophysica Acta - Gene Structure and Expression. 1992;1129(2):235-238.

8
144.
1992

M.S. Runge

The future of thrombolytic therapy.
Heart disease and stroke : a journal for primary care physicians. 1992;1(1):39-42.

0
145.
1992

D.J. Hayzer; P.M. Rose; J.S. Lynch; M.L. Webb; B.K. Kienzle; E.C.K. Liu -; E.A. Bogosian; E. Brinson; M.S. Runge

Cloning and expression of a human endothelin receptor: Subtype A
American Journal of the Medical Sciences. 1992;304(4):231-238.

7
146.
1992

D.J. Hayzer; E. Brinson; M.S. Runge

A rat β-interferon-induced mRNA: Sequence characterization
Gene. 1992;117(2):277-278.

14
147.
1992

C. Zhong; D.J. Hayzer; M.A. Corson; M.S. Runge

Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor
Journal of Biological Chemistry. 1992;267(24):16975-16979.

107
148.
1992

Christoph Bode; Marschall S. Runge; Edgar Haber

Purifying antibody-plasminogen activator conjugates
Bioconjugate Chemistry. 1992;3(4):269-272.

2
149.
1992

E. Haber; C. Bode; G.R. Matsueda; G.L. Reed; M.S. Runge

Antibody targeting as a thrombolytic strategy
Annals of the New York Academy of Sciences. 1992;667:365-381.

6
150.
1991

T.J. Murphy; R. Wayne Alexander; Kathy K. Griendling; Marschall S. Runge; Kenneth E. Bernstein

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Nature. 1991;351(6323):233-236.

723
151.
1991

C. Bode; G. Meinhardt; M.S. Runge; M. Freitag; T. Nordt; M. Arens; J.B. Newell; W. Kubler; E. Haber

Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation
Circulation. 1991;84(2):805-813.

34
152.
1991

Marschall S. Runge; Thomas Quertermous; Paul J. Zavodny; Ted W. Love; Christoph Bode; Mathias Freitag; Shyh-Yu Shaw; Paul L. Huang; Chuan-Chu Chou; Debora Mullins; et al.

A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo
Proceedings of the National Academy of Sciences of the United States of America. 1991;88(22):10337-10341.

29
153.
1991

M.S. Runge

New horizons in the treatment of coronary artery thrombosis
American Journal of the Medical Sciences. 1991;301(1):21-27.

0
154.
1991

David J. Hayzer; Ira M. Lubin; Marschall S. Runge

Conjugation of plasminogen activators and fibrin-specific antibodies to improve thrombolytic therapeutic agents
Bioconjugate Chemistry. 1991;2(5):301-308.

10
155.
1991

M.S. Runge; C. Bode; E. Haber; T. Quertermous

Hybrid molecules: Insights into plasminogen activator function
Molecular Biology and Medicine. 1991;8(2):245-255.

3
156.
1991

C. Cockerham; M.L. Webb; S.A. Hedberg; M.S. Runge

Regulation of the rat aortic smooth muscle cell thromboxane A2 receptor.
Transactions of the Association of American Physicians. 1991;104:173-180.

6
157.
1991

C. Bode; T. Nordt; U. Detlefs-Bartels; M.S. Runge; M. Arens; W. Kübler; E. Haber

Targeting of single-chain urokinase plasminogen activator by conjugation to an antiplatelet antibody results in enhanced clot lysis.
Transactions of the Association of American Physicians. 1991;104:29-31.

1
158.
1991

M.S. Runge; E. Haber

Importance of experimental models in study of thrombosis and thrombolysis
Circulation. 1991;83(6 SUPPL.):IV-1-IV-2.

2
159.
1990

E. Haber; T. Quertermous; G.R. Matsueda; M.S. Runge; C. Bode

Antibody-targeted thrombolytic agents
Japanese Circulation Journal. 1990;54(4):345-353.

0
160.
1990

E.E. Branscomb; M.S. Runge; C.E. Savard; K.M. Adams; G.R. Matsueda; E. Haber

Bispecific monoclonal antibodies produced by somatic cell fusion increase the potency of tissue plasminogen activator
Thrombosis and Haemostasis. 1990;64(2):260-266.

8
161.
1990

M.S. Runge

Prevention of thrombosis and rethrombosis. New approaches
Circulation. 1990;82(2):655-657.

3
162.
1990

C. Bode; M.S. Runge; S. Schonermark; T. Eberle; J.B. Newell; W. Kubler; E. Haber

Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator
Circulation. 1990;81(6):1974-1980.

22
163.
1990

C. Bode; M.S. Runge; E. Haber

Future directions in plasminogen activator therapy
Clinical Cardiology. 1990;13(6):375-381.

2
164.
1990

John R. Charpie; Marschall S. Runge; Gary R. Matsueda; Edgar Haber

A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase
Biochemistry. 1990;29(27):6374-6378.

10
165.
1990

Marschall S. Runge; Christoph Bode; Christopher E. Savard; Gary R. Matsueda; Edgar Haber

Antibody-directed fibrinolysis: A bispecific (Fab′)₂ that binds to fibrin and tissue plasminogen activator
Bioconjugate Chemistry. 1990;1(4):274-277.

5
166.
1990

C. Bode; T. Eberle; M. Runge; E. Haber; W. Kubler

A hybrid molecule from prourokinase and a fibrin-specific monoclonal antibody fragment is thrombolytically more effective than prourokinase in vitro and in vivo
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin. 1990;96:1-3.

0
167.
1989

C. Bode; M.S. Runge; E.E. Branscomb; J.B. Newell; G.R. Matsueda; E. Haber

Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activator
Journal of Biological Chemistry. 1989;264(2):944-948.

14
168.
1989

E. Haber; T. Quertermous; G.R. Matsueda; M.S. Runge

Innovative approaches to plasminogen activator therapy
Science. 1989;243(4887):51-56.

36
169.
1989

M.S. Runge; T. Quertermous; E. Haber

Plasminogen activators. The old and the new
Circulation. 1989;79(2):217-224.

8
170.
1989

C. Bode; M. Runge; T. Eberle; M. Freitag; W. Kübler; E. Haber

Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
Transactions of the Association of American Physicians. 1989;102:7-12.

0
171.
1989

T.W. Love; M.S. Runge; E. Haber; T. Quertermous

Recombinant antibodies possessing novel effector functions
Methods in Enzymology. 1989;178:515-527.

4
172.
1989

C. Bode; M.S. Runge; E. Haber

Improving on nature: antibody-targeted enzymes.
The Year in immunology. 1989;6:185-196.

1
173.
1988

M.S. Runge; T. Quertermous; G.R. Matsueda; E. Haber

Increasing selectivity of plasminogen activators with antibodies
Clinical Research. 1988;36(5):501-506.

0
174.
1988

Marschall S. Runge; Christoph Bode; Gary R. Matsueda; Edgar Haber

Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro
Biochemistry. 1988;27(4):1153-1157.

8
175.
1988

E.B. Grossbard; J.H. Chesebro; G. Knatterud; E. Braunwald; A.M. Ross; M.L. Simoons; M. Verstraete; S. Gerard; J. Levin; M.S. Runge; et al.

Thrombolytic therapy
New England Journal of Medicine. 1988;319(23):1543-1547.

1
176.
1987

C. Bode; M.S. Runge; J.B. Newell; G.R. Matsueda; E. Haber

Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin
Journal of Biological Chemistry. 1987;262(22):10819-10823.

11
177.
1987

Christoph Bode; Marschall S. Runge; John B. Newell; Gary R. Matsueda; Edgar Haber

Thrombolysis by a fibrin-specific antibody fab′-urokinase conjugate
Journal of Molecular and Cellular Cardiology. 1987;19(4):335-341.

6
178.
1987

J.M. Schnee; M.S. Runge; G.R. Matsueda; N.W. Hudson; J.G. Seidman; E. Haber; T. Quertermous

Construction and expression of a recombinant antibody-targeted plasminogen activator.
Proceedings of the National Academy of Sciences of the United States of America. 1987;84(19):6904-6908.

18
179.
1987

M.S. Runge; C. Bode; G.R. Matsueda; E. Haber

Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo.
Proceedings of the National Academy of Sciences of the United States of America. 1987;84(21):7659-7662.

31
180.
1987

M.S. Runge; C. Bode; G.R. Matsueda; E. Haber

Antibody-enhanced thrombolysis: capture of tissue plasminogen activator by a bispecific antibody and direct targeting by an antifibrin-tissue plasminogen activator conjugate in vivo.
Transactions of the Association of American Physicians. 1987;100:250-255.

0
181.
1984

P.C.H. Tseng; M.S. Runge; J.A. Cooper; R.C. Williams Jr.; T.D. Pollard

Physical, immunochemical, and functional properties of Acanthamoeba profilin
Journal of Cell Biology. 1984;98(1):214-221.

24
182.
1983

R.C. Williams Jr.; M.S. Runge

Biochemistry and structure of mammalian neurofilaments.
Cell and muscle motility. 1983;3:41-56.

4
183.
1982

M.S. Runge; R.C. Williams Jr.

Formation of an ATP-dependent microtubule-neurofilament complex in vitro.
Cold Spring Harbor Symposia on Quantitative Biology. 1982;46 Pt 1:483-493.

1
184.
1981

M.S. Runge; T.M. Laue; D.A. Yphantis; M.R. Lifsics; A. Saito; M. Altin; K. Reinke; R.C. Williams Jr.

ATP-induced formation of an associated complex between microtubules and neurofilaments.
Proceedings of the National Academy of Sciences of the United States of America. 1981;78(3):1431-1435.

12
185.
1981

Marschall S. Runge; M. Raafat El-Maghrabi; Thomas H. Claus; Simon J. Pilkis; Robley C. Williams Jr.

A MAP-2-stimulated protein kinase activity associated with neurofilaments
Biochemistry. 1981;20(1):175-180.

8
186.
1981

Marschall S. Runge; William W. Schlaepfer; Robley C. Williams Jr.

Isolation and characterization of neurofilaments from mammalian brain
Biochemistry. 1981;20(1):170-175.

1
187.
1979

Marschall S. Runge; H. William Detrich III; Robley C. Williams Jr.

Identification of the major 68 000-dalton protein of microtubule preparations as a 10-nm filament protein and its effects on microtubule assembly in vitro
Biochemistry. 1979;18(9):1689-1698.

3
188.
1979

M.S. Runge; P.B. Hewgley; D. Puett; R.C. Williams Jr.

Cyclic nucleotide phosphodiesterase activity in 10-nm filaments and microtubule preparations from bovine brain
Proceedings of the National Academy of Sciences of the United States of America. 1979;76(6):2561-2565.

2

Marschall S Runge UNCCH, School of Medicine, Medicine

Marschall S Runge

188 Publications

Marschall S Runge
UNCCH, School of Medicine, Medicine